LJPC DD sheet.
La Jolla Pharmaceutical Company is a biopharmaceutical company dedicated to the development of treatments that significantly improve outcomes in patients with life-threatening diseases. Our team is pioneering the science of galectins to develop innovative new therapies to treat human diseases such as cancer and chronic organ failure.
WebSite.
http://www.ljpc.com/technology-galectins.html
Shares Outstanding 12,338,960 a/o May 18, 2012
Float Not Available
Authorized Shares Not Available
Par Value 0.01
•Capital Change=shs decreased by 1 for 100 split. Pay date=02/17/2012.
http://www.otcmarkets.com/stock/LJPC/company-info
10-Q: 5/21/12
http://ih.advfn.com/p.php?pid=nmona&article=52501866
10-K: 3/30/12
http://ih.advfn.com/p.php?pid=nmona&article=51847047
Insider Buys: 4/10/12
http://www.otcmarkets.com/stock/LJPC/insider-transactions
Coporate Presentation:
http://www.ljpc.com/resources/LJPC-CorpPreso.pdf
7/20/12 Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
http://ih.advfn.com/p.php?pid=nmona&article=53544508
5/31/12 Issuance of U.S. Patent Covering Modified Pectin Compositions
http://ih.advfn.com/p.php?pid=nmona&article=52620720
4/25/12 LifeSci Advisors Initiates Coverage of La Jolla Pharmaceutical Company
http://ih.advfn.com/p.php?pid=nmona&article=52146398
4/16/12 Announces Development Programs for Lead Product, GCS-100
http://ih.advfn.com/p.php?pid=nmona&article=52014206
Galectins - have a broad range of functions, including mediation of cell survival and adhesion, promotion of cell-cell interactions, growth of blood vessels, immune regulation and inflammation.
http://www.ljpc.com/technology-galectins.html
The unique ability of GCS-100, to bind and sequester galectin-3 makes it an ideal candidate to prevent and treat diseases in which galectin-3 plays an important role, such as chronic organ failure and cancer
Product PipeLine. http://www.ljpc.com/pipeline-main.html
A great set of Cell videos when watched on YouTube.
La Jolla Pharmaceutical Company is a biopharmaceutical company dedicated to the development of treatments that significantly improve outcomes in patients with life-threatening diseases. Our team is pioneering the science of galectins to develop innovative new therapies to treat human diseases such as cancer and chronic organ failure.
WebSite.
http://www.ljpc.com/technology-galectins.html
Shares Outstanding 12,338,960 a/o May 18, 2012
Float Not Available
Authorized Shares Not Available
Par Value 0.01
•Capital Change=shs decreased by 1 for 100 split. Pay date=02/17/2012.
http://www.otcmarkets.com/stock/LJPC/company-info
10-Q: 5/21/12
http://ih.advfn.com/p.php?pid=nmona&article=52501866
10-K: 3/30/12
http://ih.advfn.com/p.php?pid=nmona&article=51847047
Insider Buys: 4/10/12
http://www.otcmarkets.com/stock/LJPC/insider-transactions
Coporate Presentation:
http://www.ljpc.com/resources/LJPC-CorpPreso.pdf
7/20/12 Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
http://ih.advfn.com/p.php?pid=nmona&article=53544508
5/31/12 Issuance of U.S. Patent Covering Modified Pectin Compositions
http://ih.advfn.com/p.php?pid=nmona&article=52620720
4/25/12 LifeSci Advisors Initiates Coverage of La Jolla Pharmaceutical Company
http://ih.advfn.com/p.php?pid=nmona&article=52146398
4/16/12 Announces Development Programs for Lead Product, GCS-100
http://ih.advfn.com/p.php?pid=nmona&article=52014206
Galectins - have a broad range of functions, including mediation of cell survival and adhesion, promotion of cell-cell interactions, growth of blood vessels, immune regulation and inflammation.
http://www.ljpc.com/technology-galectins.html
The unique ability of GCS-100, to bind and sequester galectin-3 makes it an ideal candidate to prevent and treat diseases in which galectin-3 plays an important role, such as chronic organ failure and cancer
Product PipeLine. http://www.ljpc.com/pipeline-main.html
A great set of Cell videos when watched on YouTube.
5-Bagger contest on "Dawgg".
http://bit.ly/qthbYc
Sleepers!
http://bit.ly/Lbsa79
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
